Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab versus docetaxel in previously treated advanced or metastatic squamous non-small cell lung cancer
2011-004792-36Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jul 2012
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nivolumab, docetaxel in Pulmonary squamous cell carcinoma, sponsored by Bristol Myers Squibb. Started Jul 2012; status: completed.
02
Drugs
nivolumabdocetaxel
03
Conditions
Pulmonary squamous cell carcinoma
Beyond the preview
Go deeper on 2011-004792-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004792-36.